Log In
BCIQ
Print this Print this
 

RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)

BCIQ
Print ChartPrint this
1 - Autoimmune 3 - Autoimmune 1 - Pulmonary 1 - Inflammation 1 - Endocrine / Metabolic 1 - Autoimmune
Phase of DevelopmentPreclinicalPhase IPhase II
Autoimmune

1

3

1

Endocrine / Metabolic

1

-

-

Inflammation

1

-

-

Pulmonary

1

-

-




 Products Targeting RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$639.0M

$639.0M

$135.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today